2016
DOI: 10.21276/ijmrp.2016.2.4.024
|View full text |Cite
|
Sign up to set email alerts
|

Association of Ki-67 Proliferative Index with Clinico-Pathological Features of Non-Hodgkin’s Lymphoma Classified According to WHO (2008)

Abstract: Background: Lack of proper knowledge and faulty practices in biomedical waste management is common in developing countries like India. This study was conducted in the department of surgery of a tertiary level hospital attached with medical college. The purpose of the study was to evaluate lacunae in disposal of hospital generated wastes and recommend steps to rectify the prevalent scenario. Material and Methods: An observational cross sectional study was undertaken in the department of surgery, J.L.N. Medical … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…Visual assessment (VA) of the proliferative index was performed by two experienced hematopathologists (AB, BZ). The percentage of positive tumor cells was estimated in 5% steps up to 20% and in 10% steps thereafter (i.e., 5,10,15,20,30,40,50,60,70,80,90,100). Slides were reviewed at low power (2.5 £) using a standard microscope (BX 50 Olympus), and for a final evaluation of the proliferative index, at least three different fields-of-view at high magnification (40 £) were chosen by the pathologists.…”
Section: Immunohistochemistrymentioning
confidence: 99%
See 1 more Smart Citation
“…Visual assessment (VA) of the proliferative index was performed by two experienced hematopathologists (AB, BZ). The percentage of positive tumor cells was estimated in 5% steps up to 20% and in 10% steps thereafter (i.e., 5,10,15,20,30,40,50,60,70,80,90,100). Slides were reviewed at low power (2.5 £) using a standard microscope (BX 50 Olympus), and for a final evaluation of the proliferative index, at least three different fields-of-view at high magnification (40 £) were chosen by the pathologists.…”
Section: Immunohistochemistrymentioning
confidence: 99%
“…First, different Ki67 cutoff values have been described for indolent, more aggressive, and highly aggressive lymphomas across a range of studies, which is likely due to the inclusion of different lymphoma subsets [6,8,10,11]. Second, differences in therapeutic approaches have occurred over time, particularly because anti-CD20 immunotherapy has entered clinical routine, concerning the impact of Ki67 staining on clinical outcome [5].…”
mentioning
confidence: 99%